ВРТ1. Название Стр
Скачать 1.93 Mb.
|
2014;41(2):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627 338. Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil Steril [Internet]. 2010;94(2):496–501. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589517 339. Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(3 Pt 2):S52--6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921 340. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009;19(3):343– 51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479 341. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000;15(1):165–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207 342. Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG- primed in vitro maturation cycles. Hum Reprod [Internet]. 2008;23(12):2680–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885 343. Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009;92(3):907– 12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750 344. Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007;110(4):885–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024 345. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601–8. 346. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May;99(6):1476–84. 347. Coyne K, Purdy M, O†TM Leary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front Public Heal [Internet]. 2014;2. Available from: http://journal.frontiersin.org/article/10.3389/fpubh.2014.00246/abstract 348. Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin 169 (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet [Internet]. 2014;31(7):927–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484 349. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet]. 2012;97(5):1039–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086 350. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ. What exactly do we mean by “recurrent implantation failure”? A systematic review and opinion. Reprod Biomed Online [Internet]. 2014;28(4):409–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24581986 351. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online [Internet]. 2014;28(1):14–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24269084 352. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2013г. Проблемы репродукции. 2015;21(6):16–32. 353. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2014г. Проблемы репродукции. 2016;22(5):8–21. 354. European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, de Geyter C, Kupka MS, de Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Hum Reprod. 2016;31(8):1638–52. 355. Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril [Internet]. 1987;48(6):1051–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3678505 356. Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol [Internet]. 1986;155(3):480–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3752170 357. Chauhan M, Barratt CL, Cooke SM, Cooke ID. Differences in the fertility of donor insemination recipients--a study to provide prognostic guidelines as to its success and outcome. Fertil Steril [Internet]. 1989;51(5):815–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2707456 358. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update [Internet]. 15(3):265–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240042 359. Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review. Hum Reprod [Internet]. 2003;18(5):941–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12721166 360. Green KA, Zolton JR, Schermerhorn SM V, Lewis TD, Healy MW, Terry N, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril [Internet]. 2017;107(4):924-- 933.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28238492 |